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ABSTRACT
Objective: To explore why patients with cancer
treated by London hospitals report worse experiences
of care compared with those treated in other English
regions.
Design: Secondary analysis of the 2011/2012 National
Cancer Patient Experience Survey (n=69 086).
Setting and participants: Patients with cancer
treated by the English National Health Service (NHS)
hospitals.
Main outcome measures: 64 patient experience
measures covering all aspects of cancer care (pre-
diagnosis to discharge).
Methods: Using mixed effects logistic regression, we
explored whether poorer scores in London hospitals
could be explained by patient case-mix (age, gender,
ethnicity and cancer type). Because patients referred
to tertiary centres and/or with complex medical
problems may report more critical experiences, we
also explored whether the experiences reported in
London may reflect higher concentration of teaching
hospitals in the capital. Finally, using the data from
the (general) Adult Inpatients Survey, we explored
whether the extent of poorer experience reported by
London patients was similar for respondents to either
survey.
Results: For 52/64 questions, there was evidence of
poorer experience in London, with the percentage of
patients reporting a positive experience being lower
compared with the rest of England by a median of
3.7% (IQR 2.5–5.4%). After case-mix adjustment
there was still evidence for worse experience in
London for 44/64 questions. In addition, adjusting for
teaching hospital status made trivial difference to the
case-mix-adjusted findings. There was evidence that
London versus rest-of-England differences were
greater for patients with cancer compared with
(general) hospital inpatients for 10 of 16 questions in
both the Cancer Patient Experience and the Adult
Inpatients Surveys.
Conclusions: Patients with cancer treated by London
hospitals report worse care experiences and by and
large these differences are not explained by patient
case-mix or teaching hospital status. Efforts to
improve care in London should aim to meet patient
expectations and improve care quality.
INTRODUCTION/BACKGROUND
Understanding the variation in patient
experience can help to inform priorities for
improvement actions and policies. In the
UK, the advent of large national surveys of
patients with cancer has enabled a better
appreciation of variation in cancer patient
experience between different patient groups
or hospitals.1–4 A salient finding of recent
cancer patient surveys is that patients treated
by London hospitals reported poorer experi-
ences compared with those treated by hospi-
tals in other English regions.1 5–7
Several hypotheses can be considered to
explain this type of geographical variation in
crude hospital experience scores. First,
London hospitals may be treating a higher
proportion of patient groups known to
report worse experiences of care, such as
younger and ethnic minority patients or
patients with certain types of cancer.2 3 8 9
Second, patient experience may vary by type
of hospital, and if so, the experiences
reported in London could simply reflect a
higher concentration of teaching (tertiary)
hospitals in the capital region.7 This hypoth-
esis assumes that patients who are referred to
tertiary centres and/or have complex
medical problems and/or have more
complex care pathways are likely to be more
critical of their experiences. Third, it is pos-
sible that London patients receive the same
Strengths and limitations of this study
▪ Data comes from a large nationwide survey of
patients with any cancer.
▪ The survey has a high (68%) response rate.
▪ We have not been able to directly examine the
potential influence of differences in expectations
of care quality between patients treated by
London hospitals and hospitals elsewhere in
England.
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care as that received by patients elsewhere but have
higher expectations of care quality, perhaps because of
different cultural expectations, leading to a more critical
evaluation of their experience (the ‘same care worse
experience’ hypothesis).8 Fourth, care provided by
London hospitals may indeed be different (worse) com-
pared with the rest of the country, leading to worse
experience.
Understanding the potential mechanisms responsible
for poorer reported experience of cancer patients
treated by London hospitals is important to inform
efforts to address this disparity. In this paper we set out
to directly explore whether London/rest-of-England
inequalities in cancer patient experience may reflect
confounding by sociodemographic or cancer diagnosis
case-mix and/or hospital type. In addition, we consider
indirect evidence to provide insights about other poten-
tial sources of variation, beyond case-mix and hospital
type.
METHODS
Data
Sources
For the main analysis we used publicly available anonym-
ous data from the 2011/2012 National Cancer Patient
Experience Survey—a postal survey of patients with
cancer treated by 160 English NHS hospitals during
January–March 2012 (71 793 respondents, response rate
68%) carried out by Quality Health for the Department
of Health.10 Of all respondents, 3.8% had missing self-
reported ethnic group and were excluded, with the final
analysis sample of 69 086. For each question, we
included in analysis all patients with an informative
response to the question of interest.
In further analysis we used data from the Adult
Inpatients Survey, a postal survey of patients with any
pathology and at least one night stay in an NHS hospital
between June and August 2011 (70 863 respondents,
response rate 53%) carried out by the Picker Institute
for the Care Quality Commission.11 Of all respondents,
three had missing age and were excluded with a final
analysis sample of 70 860.
Outcome and exposure variables
Of all 160 English hospitals treating patients with cancer,
27 are London hospitals and 26 are teaching hospitals
(ie, university hospitals with a tertiary referral centre
function; see online supplementary appendix table 1).
Eight teaching hospitals are also London hospitals.
The Cancer Patient Experience Survey comprises 65
questions that measure patient experience across the
patients with cancer journey. Most questions have a four-
point or five-point Likert scale response options, evaluat-
ing experience from very good to very poor. As public
reporting of hospital scores for the survey is based on
binary forms of these outcomes (ie, good or poor patient
experience),1 we used the same binary categorisations in
the analysis. There are 16 Cancer Patient Experience
Survey questions that are also included in the Adult
Inpatients Survey. Information on cancer diagnosis
International Classification of Diseases (ICD)-10 code,
patient age and gender were available for all respondents
based on hospital record information. Thirty-six different
cancer diagnoses groups were considered (see online
supplementary appendix table 2). Age was categorised
into eight groups (16–24, six 10-year groups from 25–34
to 75–84 and 85+). We used patients’ self-reported ethni-
city (based on their responses to survey question 77) in
this study rather than relying on information recorded in
hospital records as the former is considered to be a gold
standard and the latter has been shown to contain some
inaccuracies.12 A six-group classification (White, Mixed,
Asian or Asian British, Black or Black British, Chinese
and Other) was used in the analysis.
Analysis
Exploratory analysis showed that variation among the
English regions other than London was trivial (see
online supplementary appendix table 3). Therefore,
hereafter all analysis relates to London/rest-of-England
comparisons, with patients treated by ‘rest-of-England’
hospitals considered together as a group.
We first described London/rest-of-England variation
in the sociodemographic and clinical characteristics of
respondents.
We then used mixed effects logistic regression (includ-
ing a random effect for hospital) to estimate the OR for
patients with cancer treated by London hospitals report-
ing poorer experience compared with those treated by
hospitals elsewhere in England. We considered three
models separately for each of the survey questions. To
explore crude (unadjusted) differences, the first model
included only a fixed effect variable denoting London/
rest-of-England hospital location (in addition to a
random effect for hospital, as above). To explore the
potential influence of patient case-mix, the second
model additionally included case-mix variables (patient
age, gender, ethnic group and cancer diagnosis). Finally,
to explore the potential influence of teaching hospital
status, the third model, in addition to sociodemographic
characteristics and cancer diagnosis also adjusted for
whether or not the hospital of treatment was a teaching
hospital. We plotted the p values from these fully
adjusted models to evaluate the role of chance in these
findings. For one question (question 28, whether a
patient was pleased to have been asked to take part in
cancer research), the adjusted model did not converge,
as patient experience was almost uniformly positive
across all hospitals in England. This question was there-
fore excluded from all analyses, and the results hereafter
relate to 64 evaluative questions. We also explored inter-
actions between London hospital and sociodemographic
characteristics which allow us to explore whether any
particular groups of patients report particularly different
experiences in London; for ethnic groups specifically,
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because interaction models include a large number of
degrees of freedom, we considered a broad two-group
classification of ethnicity (white/non-white).
Finally, we combined data from the two hospital
surveys (Cancer Patient Experience Survey and Adult
Inpatients Survey) to test whether differences in experi-
ence reported by patients treated by London hospitals
were consistent across the two surveys. After adjusting for
age and gender, using this model, we tested whether the
association between London hospital location and
patient experience was consistent between surveys for
the 16 questions that they both share. All analyses were
carried out using Stata V.11.2.
RESULTS
Patient characteristics
On an average, compared with cancer patients treated
elsewhere in England, those treated by London hospitals
were younger (median age of 65 vs 66 years), more likely
to belong to ethnic minorities (16% vs 2%), more likely
to be treated by teaching hospitals (46% vs 24%) and
more likely to suffer from rarer types of cancers
(eg,6.5% vs 4.4% had multiple myeloma, table 1).
Unadjusted differences in positive experience
There was evidence (p<0.05) that patients with cancer
treated by London hospitals reported worse experiences
compared with those treated by hospitals in the
rest-of-England for 52 of 64 survey questions (figure 1,
full results in online supplementary appendix table 4b).
For a single question (whether the patient was asked to
take part in cancer research) experience was more posi-
tive in London while for nine other questions there was
no evidence of difference (see online supplementary
appendix table 4b). Depending on item non-response
and the frequency of positive responses observed
(unadjusted and adjusted), effect sizes of OR∼1.1 are
significant at p<0.05.
For the 52 questions with worse experience in
London, the proportion of patients reporting a positive
experience was lower in London compared with the
rest-of-England by a median of 3.7% (IQR 2.5–5.4%, for
full details by question, see online supplementary appen-
dix table 4a). For these questions the unadjusted ORs
(for London patients reporting worse experience)
ranged from 1.13 to 2.05. The most pronounced differ-
ence was for the question on whether staff asked patients
about the name by which they would like to be called
(unadjusted OR for worse experience in London=2.05
(1.75–2.41)).
Variation in experience adjusted for patient case-mix
After accounting for differences in case-mix, the size of
London/rest-of-England differences in patient experi-
ence was attenuated, but there was still evidence
(p<0.05) that patient experience was worse in London
hospitals for 45 of 64 questions (figure 1 and see online
supplementary appendix table 4b).
Adjustment for teaching hospital status
Adjusting for teaching hospital status (additional to
adjustment for case-mix) made minimal difference to
the size of London/rest-of-England differences: there
remained evidence that patient experience was worse in
London (p<0.05) for 44 of 64 survey questions, with
effect sizes that were nearly identical to those observed
after case-mix adjustment (figure 1 and see online sup-
plementary appendix table 4b). Specific aspects of vari-
ation are further highlighted in box 1. The observed
and expected distribution of p values under the null
hypothesis was plotted from these models (figure 2).
The significant associations observed are unlikely to be
due to chance alone.
Interaction analysis
There was little evidence for interactions between treat-
ment by a London hospital and sociodemographic char-
acteristics. Full results for ethnicity are presented in
online supplementary appendix 5. Briefly, the results
suggest that the impact of being treated by a London
hospital is the same irrespective of the ethnic back-
ground of the patient. Another way to consider this
would be that although ethnic minority patients gener-
ally report worse care than White patients there is no
evidence that this disparity is any larger or smaller in
London hospitals.
London variation for patients with cancer and general in
patients
For 16 questions that are consistent across both surveys,
reported experience was generally more positive for
patients with cancer (Cancer Patient Experience Survey
respondents) compared with patients with a general mix
of diagnoses (Adult Inpatients Survey respondents). Being
treated in London appears to have a more negative impact
on patient experience among patients with cancer than
among general hospital inpatients, with statistical evidence
for such an interaction for 10 of the 16 questions that are
common across the two surveys (table 2).
DISCUSSION
We explored the potential sources of variation in the
experience of patients with cancer treated by London
hospitals compared with those treated by hospitals else-
where in England. Considering unadjusted percentages,
cancer patient experience in London is rated worse
than any other English region for the great majority of
questions, although the absolute percentage difference
is typically small. Confounding by patient case-mix
(sociodemographic characteristics or cancer diagnosis)
explains some of the London/rest-of-England disparities
but its overall impact is small. Additional adjustment for
teaching hospital status has only a marginal influence.
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Table 1 Comparison of patients with cancer treated by London hospitals with those treated elsewhere in England
Age All Per cent Rest-of-England Per cent London Per cent
16–24 355 0.5 275 0.5 80 0.9
25–34 954 1.4 756 1.3 198 2.3
35–44 2999 4.3 2492 4.1 507 5.8
45–54 8911 12.9 7637 12.7 1274 14.6
55–64 16 970 24.6 14 820 24.6 2150 24.6
65–74 22 749 32.9 20 168 33.4 2581 29.5
75–84 13 564 19.6 11 901 19.7 1663 19.0
85+ 2584 3.7 2289 3.8 295 3.4
Age median (IQR) 66 (58–74) 66 (58–74) 65 (55–73)
Gender
Men 32 463 47.0 28 398 47.1 4065 46.5
Women 36 623 53.0 31 940 52.9 4683 53.5
Ethnic group
White 66 421 96.1 59 071 97.9 7350 84.0
Mixed 278 0.4 151 0.3 127 1.5
Asian 1146 1.7 633 1.0 513 5.9
Black 949 1.4 334 0.6 615 7.0
Chinese 150 0.2 87 0.1 63 0.7
Other 142 0.2 62 0.1 80 0.9
Teaching hospital 18 758 27.2 14 711 24.4 4047 46.3
Other hospital type 50 328 72.8 45 627 75.6 4701 53.7
Cancer diagnosis
Breast 13 396 19.4 11 742 19.5 1654 18.9
DCIS 916 1.3 788 1.3 128 1.5
Ovarian 1823 2.6 1550 2.6 273 3.1
Endometrial 1478 2.1 1280 2.1 198 2.3
Cervical 405 0.6 355 0.6 50 0.6
Vulval/vaginal 236 0.3 206 0.3 30 0.3
Other gynaecological 88 0.1 74 0.1 14 0.2
Thyroid 493 0.7 434 0.7 59 0.7
Laryngeal 361 0.5 319 0.5 42 0.5
Other head and neck 1280 1.9 1136 1.9 144 1.6
Non-Hodgkin lymphoma 4290 6.2 3781 6.3 509 5.8
Multiple myeloma 3236 4.7 2667 4.4 569 6.5
Leukaemia 2479 3.6 2075 3.4 404 4.6
Hodgkin lymphoma 487 0.7 411 0.7 76 0.9
Rectal 3541 5.1 3176 5.3 365 4.2
Colon 5054 7.3 4516 7.5 538 6.1
Anal 242 0.4 213 0.4 29 0.3
Other lower gastrointestinal 215 0.3 182 0.3 33 0.4
Lung 3698 5.4 3237 5.4 461 5.3
Mesothelioma 392 0.6 346 0.6 46 0.5
Brain 483 0.7 397 0.7 86 1.0
Other central nervous system 59 0.1 39 0.1 20 0.2
Oesophageal 1362 2.0 1209 2.0 153 1.7
Stomach 1019 1.5 906 1.5 113 1.3
Pancreatic 673 1.0 569 0.9 104 1.2
Hepatobiliary/gallbladder 568 0.8 439 0.7 129 1.5
Bladder 6503 9.4 5808 9.6 695 7.9
Prostate 5568 8.1 4897 8.1 671 7.7
Renal 950 1.4 839 1.4 111 1.3
Other urological 349 0.5 309 0.5 40 0.5
Testicular 256 0.4 217 0.4 39 0.4
Secondary 4308 6.2 3740 6.2 568 6.5
Melanoma 1546 2.2 1420 2.4 126 1.4
Soft tissue sarcoma 575 0.8 447 0.7 128 1.5
Bone sarcoma 174 0.3 125 0.2 49 0.6
Any other cancer diagnosis 583 0.8 489 0.8 94 1.1
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The observed distribution of p values across questions
would indicate that these findings are unlikely to be
explained by chance alone (figure 2). There is some evi-
dence that London/rest-of-England differences in
patient experience are larger for patients with cancer
than patients with a general mix of diagnoses. These
findings indicate that the hypotheses that London/
rest-of-England differences in patient experience reflect
either patient case-mix or teaching hospital status are
unlikely to be true.
Figure 1 London/
rest-of-England differences in
patient experience across the
Cancer Patient Experience
Survey questions. OR values
>1.0 indicate that cancer patients
treated by London hospitals
report comparatively worse
experience of care than patients
treated elsewhere, and vice
versa.
Figure 2 Variation in observed p values for the association
between being treated at a London hospital and reported
patient experience after adjustment for case-mix and teaching
hospital status. The observed variation is compared with that
which we might expect under the null hypothesis of no
association (line). If there were no true associations, then
three or four (ie, ∼5%) of the 64 questions would be expected
to have a p value of less than 0.05 (red line) by chance alone
and the observed distribution would follow the expected
straight line. Multiple testing is unlikely to be the explanation
for the distribution observed in these analyses.
Box 1 Aspects of London/rest-of-England variation in
cancer patient experience
Considering different questions across the patient journey,
patients treated by London hospitals generally report worse
experiences throughout (diagnosis, treatment, discharge and
postdiagnosis). Furthermore, worse experience in London is
apparent for questions relating to the experience of hospital care
and for the (fewer) questions that relate to the experience of
primary or social care. For example, patients treated by London
hospitals reported worse experience for questions 1–4 (relating to
pre-diagnosis experience, including aspects of care provided by
general practitioners) and for question 55 (care from health and
social services after discharge from hospital).
Few questions without evidence for worse experience in London
hospitals include questions about treatment choice (question 15,
whether the patient was given a choice of treatment options) and
information provision (eg, question 68, on having been offered a
written care plan).
London/rest-of-England differences with respect to nursing care
were inconsistent. For two items (question 20, whether the
patient was given the name of a Cancer Nurse Specialist; and
question 43, whether there were enough ward nurses on duty),
there was no evidence of differences. However, for items relevant
to nursing care (eg, questions 21–23 regarding ease of contact-
ing a Cancer Nurse Specialist and interpersonal aspects of spe-
cialist nurse care; or questions 40–41 regarding the experience of
ward nursing) patients treated by London hospitals reported
worse experience.
The strength of the association between poorer experience of
patients in London/rest-of-England was attenuated for most ques-
tions after adjusting for case-mix and hospital type (figure 1).
Improvement efforts should be focused on questions where the
associations are strongest (see online supplementary appendix
table 4b), rather than on individual changes in p values.
Considering report or evaluation types of questions separate the
patients treated by London hospitals tended to report worse
experience for both evaluation and report items (figure 3).
Saunders CL, Abel GA, Lyratzopoulos G. BMJ Open 2014;4:e004039. doi:10.1136/bmjopen-2013-004039 5
Open Access
Table 2 Comparison of London/rest-of-England differences in patient experience for general inpatients (any pathology) and patients with cancer*
Question†
Effect of London in
general inpatients
Effect of London in
cancer patients Interaction OR
Interaction
p value
19 Patient definitely involved in decisions about which treatment 1.15 1.31 1.13 (1.06 to 1.22) 0.001
32 Staff gave complete explanation of what would be done 1.17 1.25 1.07 (0.95 to 1.20) 0.223
34 Staff explained how operation had gone in understandable way 1.14 1.13 0.99 (0.90 to 1.09) 0.392
37 Patient had confidence and trust in all doctors treating them 1.07 1.35 1.27 (1.15 to 1.40) <0.0001
38 Doctors did not talk in front of patient as if they were not there 1.17 1.47 1.25 (1.14 to 1.37) <0.0001
41 Patient had confidence and trust in all ward nurses 1.50 1.58 1.05 (0.97 to 1.14) 0.176
42 Nurses did not talk in front of patient as if they were not there 1.48 1.67 1.13 (1.03 to 1.23) 0.018
43 Always/nearly always enough nurses on duty 1.03 1.12 1.08 (1.00 to 1.17) 0.057
45 Patient never thought they were given conflicting information 1.18 1.32 1.12 (1.03 to 1.22) 0.011
47 Always given enough privacy when discussing condition/treatment 1.07 1.3 1.21 (1.10 to 1.33) 0.0001
48 Always given enough privacy when being examined or treated 1.16 1.19 1.03 (0.90 to 1.18) 0.363
51 Always treated with respect and dignity by staff 1.23 1.47 1.20 (1.09 to 1.31) 0.0005
53 Staff told patient who to contact if worried post discharge 1.17 1.58 1.35 (1.19 to 1.52) <0.0001
54 Family definitely given all information needed to help care at home 1.02 1.11 1.09 (0.99 to 1.19) 0.077
67 Given the right amount of information about condition and treatment 1.05 1.20 1.14 (1.04 to 1.25) 0.010
70 Overall rating of care 1.24 1.49 1.20 (1.09 to 1.31) 0.0002
*OR values > 1 indicate that the experience of patients treated by London hospitals was worse for patients with cancer (respondents to the Cancer Patient Experience Survey, CPES) compared
with patients with a general mix of diagnoses (respondents to the Adult Inpatients Survey respondents).
†Relates to 16 questions that are common in both surveys. Question numbering relates to CPES questions.
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Previous work has documented that London patients
have worse experience of primary and hospital care.13–15
By and large regional differences in the UK are confined
to London/rest-of-England variation, which is a matter of
ongoing policy concern and improvement initiatives.16
Research from Canada has demonstrated rural–urban dif-
ferences in patient experience, with patients in urban
areas reporting worse experience.17 Our study is reminis-
cent of a study exploring geographical variation in patient
experience within the context of the Medicare’s
Consumer Assessment of Healthcare Providers and
Systems (CAHPS) survey in the USA, specifically exploring
sources of variation between California and the rest of the
USA in patient experience scores.18 This study, however,
does not provide direct insights about the important ques-
tion of whether differences relate to patient expectations
or differences in care. The plurality of ‘for profit’ care pro-
viders and the fact that that survey is not focused on
patients with cancer make informative comparisons even
more difficult.
Particular strengths of our study are its large sample size
and the ability to explore potential confounding by cancer
diagnosis, in addition to ‘universal’ sociodemographic con-
founders such as age, gender and ethnicity. Certain limita-
tions should also be considered. We were not able to
adjust for disease severity, but we believe that the potential
for residual confounding by disease severity is likely to be
small, as the inclusion of cancer diagnosis in the model
made little difference to the findings. We were also not
able to explore potential confounding by a range of other
patient factors or hospital factors (such as the quality of
patient transport links, the availability of parking and hos-
pital environment and facilities in general). Importantly,
we were also not able to adjust for the patients’ socio-
economic status. However, a previous work indicates only
small and inconsistent differences in cancer patient
experience between patients of different deprivation
groups.1–3 Furthermore, in supplementary analysis that
used data from the 2010 Cancer Patient Experience
Survey, adjustment for the deprivation group of patients
(which was available for that survey) in addition to age,
gender, ethnicity and cancer diagnosis produced trivial dif-
ferences in hospital ranks (data not shown).
Having been able to directly examine and eliminate
case-mix or teaching hospital status as major sources of
variation in the experience of patients treated by
London hospitals, it is worth considering whether the
findings may reflect differential expectations of care
quality among Londoners, or worse care quality leading
to worse experience. Disentangling this research ques-
tion is fraught with substantive methodological difficul-
ties. Evaluating standardised (eg, videoed) encounters
between patients and healthcare professionals to be
rated by patients from different regions of England
could be useful, as has been shown for studies of ethnic
variation in experience.19 In the absence of other evi-
dence, it is worth considering three observations that
may be insightful. First, with a few exceptions, patients
treated by London hospitals evaluated their experience
more negatively both for evaluation and report questions
(figure 3), and this would seem to suggest that care pro-
vided by London hospitals may be worse than in other
parts of the country. This is because if the sole explan-
ation for the London/rest-of-England were that patients
treated by London hospitals had higher expectations of
quality then this factor could have been expected to
chiefly have influenced their responses to evaluation
(eg, ‘overall, how would you rate your care’?) as opposed
to report items (eg, ‘outpatient waiting times longer
than 30 minutes’). Similarly, the fact that London/
rest-of-England differences appear to be larger for
patients with cancer compared with patients with other
pathologies treated by the same hospitals would also
support the hypothesis that an exogenous factor (such
as worse quality of cancer care) may be responsible, as
opposed to an intrinsic tendency for Londoners to
evaluate their care differently to patients treated else-
where in the country. Third, we also note that some
London hospitals (including one central London teach-
ing hospital) have cancer patient experience scores that
are above the national average.1 This observation does
not support the hypothesis that patients treated by
London hospitals have different higher expectations of
care quality. It also indicates a potential for improve-
ment for the majority of London hospitals where patient
experience is poorer overall.
In brief, some indirect evidence indicates that, at least
in some part, London/rest-of-England disparities may
reflect worse care provided by London hospitals.
The possible consequences of increasing fragmenta-
tion and care pathway complexity for the experience of
patients with cancer are an ongoing concern, particu-
larly in London. In the future, it would be helpful if,
Figure 3 ORs for London/rest-of-England differences for
‘report’ and ‘evaluation’ survey items. Cancer patients treated
by London hospitals appear to be reporting worse
experiences compared with those treated elsewhere in
England for both evaluation and report items. Questions are
ordered on this graph from those with the smallest to the
largest ORs for ‘report’ and `evaluation’ questions.
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subject to cognitive validation and development, specific
questions to explore pathway complexity were included
in the survey; for example, asking participants to indi-
cate whether their current hospital of treatment was also
the hospital of diagnosis (or related questions). An alter-
native would be for such information to be produced at
the point of generating the sampling frame of the
survey, using hospital episodes statistics data.
In conclusion, the findings suggest that patient
case-mix and hospital type are unlikely to be import-
ant sources of geographical variations in the experi-
ence of patients with cancer. These realisations can
help to further motivate the clinical and managerial
engagement with improvement efforts, and appropri-
ate investment and improvement actions to address
disparities in patient experience reported by patients
with cancer treated by London hospitals. In the
absence of direct evidence about whether these dispar-
ities reflect different expectations or worse care,
future improvement efforts and research should aim
to understand how to meet patient expectations at the
same time as delivering actual improvements in care
quality.
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